Speaker Details

Diamant Thaci

Diamant Thaci

SESSIONS

S028 Late-breaking Research: Session 1
Mar 8, 2025 9:00 AM - 12:00 PM Chapin Theater - Level III

DISCLOSURES

AbbVie – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria); Almirall – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Amgen – Speaker/Faculty Education(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria); Celltrion – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria); Regeneron – Investigator(Fees), Speaker/Faculty Education(Honoraria); Samsung Bioepis – Consultant(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Target RWE – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Fees), Speaker/Faculty Education(Honoraria);